Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

Research Watch

Cell-Cycle Regulation of BRCA1 Inhibits Homologous Recombination in G1

DOI: 10.1158/2159-8290.CD-RW2015-237 Published February 2016
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading
  • Major finding: Inhibiting assembly of the BRCA1–PALB2–BRCA2 complex suppresses homologous recombination in G1 phase.

  • Mechanism: Ubiquitylation of PALB2 by CRL3–KEAP1 blocks its interaction with BRCA1, and is reversed by USP11.

  • Impact: Inducing homologous recombination in G1 cells might allow for gene targeting in nondividing cells.

Figure1

The tumor suppressors BRCA1, partner and localizer of BRCA2 (PALB2), and BRCA2 form a complex that promotes DNA double-strand break (DSB) repair by homologous recombination, which is repressed in G1 cells; however, the mechanism by which homologous recombination is suppressed is unknown. Orthwein, Noordermeer, and colleagues showed that recruiting BRCA1 to DSBs during G1 by mutating tumor protein p53 binding protein1 (53BP1) did not result in the recruitment of BRCA2 or PALB2. PALB2 interacted with BRCA2 throughout the cell cycle, but interacted with BRCA1 only during S phase, suggesting that the cell cycle controls the assembly of the BRCA1–PALB2–BRCA2 complex and prevents BRCA2 from localizing to DSBs outside of the S/G2 phases. The domain of PALB2 that interacts with kelch-like ECH-associated protein 1 (KEAP1) was required for the cell-cycle–dependent regulation of the BRCA1–PALB2 interaction. KEAP1, a substrate adaptor for a cullin 3–RING ubiquitin ligase (CRL3), was found to ubiquitylate lysine residues 20, 25, and 30 in the N-terminus of PALB2, which blocked its interaction with BRCA1 and prevented the assembly of the BRCA1–PALB2–BRCA2 complex in G1 phase. Ubiquitin specific peptidase 11 (USP11) removed ubiquitin from PALB2, promoting BRCA1–PALB2–BRCA2 complex formation. USP11 rapidly turned over in G1 cells, consistent with the loss of the BRCA1–PALB2–BRCA2 complex. Homologous recombination could be triggered in G1 cells, but required both activation of DNA-end resection and BRCA2 recruitment to DSBs. These findings reveal that the assembly of the BRCA1–PALB2–BRCA2 complex is an essential step in controlling the cell-cycle regulation of homologous recombination, and indicate that suppression of homologous recombination during G1 phase is reversible, which may have implications for therapeutic gene targeting in nondividing cells.

Orthwein A, Noordermeer SM, Wilson MD, Landry S, Enchev RI, Sherker A, et al. A mechanism for the suppression of homologous recombination in G1 cells. Nature 2015;528:422–6.

Notes

Note: Research Watch is written by Cancer Discovery editorial staff. Readers are encouraged to consult the original articles for full details. For more Research Watch, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/content/early/by/section.

  • ©2016 American Association for Cancer Research.
View Abstract
Next
Back to top
Cancer Discovery: 6 (2)
February 2016
Volume 6, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cell-Cycle Regulation of BRCA1 Inhibits Homologous Recombination in G1
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cell-Cycle Regulation of BRCA1 Inhibits Homologous Recombination in G1
Cancer Discov February 1 2016 (6) (2) 119; DOI: 10.1158/2159-8290.CD-RW2015-237

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cell-Cycle Regulation of BRCA1 Inhibits Homologous Recombination in G1
Cancer Discov February 1 2016 (6) (2) 119; DOI: 10.1158/2159-8290.CD-RW2015-237
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Notes
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Research Watch

  • Structures Identify Selpercatinib and Pralsetinib Resistance Mechanisms
  • Computational Tool Characterizes Previously Unidentified Tumor Subtypes
  • Deep Learning Algorithm Aids Breast Cancer Detection by Mammography
Show more Research Watch

Cell Cycle

  • The Frequently Amplified Gene TRIM37 Mediates PLK4 Inhibitor Response
  • The cGAS–STING Pathway Influences Taxane Response
  • p38γ Is a CDK-like Kinase That Drives Cell-Cycle Entry and Liver Tumorigenesis
Show more Cell Cycle
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement